MedTrace Logo

Zero-fluoroscopic Cryoballoon Ablation

NCT05711589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-02-03

No results posted yet for this study

Summary

This study aimed to investigate safety and efficacy of intracardiac echocardiography (ICE)-guided zero-fluoroscopic cryoballoon ablation (CBA) in patients with paroxysmal atrial fibrillation.

Conditions

  • Atrial Fibrillation Paroxysmal

Interventions

PROCEDURE

CBA was performed under intracardiac echocardiography guidance without fluoroscopy

Zero-X group: Patients undergoing ICE-guided CBA

PROCEDURE

cryoablation (CBA) was performed under fluoroscopic guidance

cryoablation (CBA) was performed under fluoroscopic guidance

Sponsors & Collaborators

  • Pusan National University Hospital

    lead OTHER

Principal Investigators

  • Hong Euy Lim, MD · Hallym University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05711589 on ClinicalTrials.gov